Novel Injection Dose and Delivery of Varicella-Zoster Virus Vaccine
The immunogenicity of low dose VZV vaccine delivered into the outer layers of skin compared with the standard dose delivered conventionally is investigated.
The immunogenicity of low dose VZV vaccine delivered into the outer layers of skin compared with the standard dose delivered conventionally is investigated.
The guideline provides current, evidence-based recommendations on the use of biologic therapies in adults, children, and young people for the treatment of psoriasis.
Preemptive use of acyclovir does not seem to reduce the duration of mechanical ventilation in critically ill patients with herpes simplex virus (HSV) oropharyngeal reactivation.
Herpes zoster is a substantial societal burden that results in significant direct, indirect, and psychosocial costs, according to the findings of a recently published systematic review.
The Advisory Committee on Immunization Practices has updated its recommendations on the use of herpes zoster vaccines.
The new adjuvant herpes zoster subunit vaccine would cost less and offer good value compared with the current live attenuated herpes zoster vaccine.
There was little difference in risk of herpes zoster among patients who were or weren’t taking biologic or systemic therapies.
Women face an especially high risk for developing herpes zoster compared with men.
The herpes zoster vaccine rates improved with the electronic notification system.